Stay Updated with Soloreg News

Looking Beyond Russia:
EAEU → GCC

Exciting developments in EAEU/Russia and Gulf Cooperation Council (GCC) countries—such as Saudi Arabia, the United Arab Emirates (UAE), Bahrain and other relations are streamlining pharma market access. At Soloreg, we're tracking these to help you expand efficiently.

 

Key Development

Description

Pharma Benefits

Economic Partnership Agreements

EAEU-UAE signed in June 2025 to boost trade/investment; potential FTAs across GCC with mutual pharma certification recognition.

Simplified cross-border approvals, easier market entry.

Harmonization of Registration Certificates

GCC's centralized procedure unifies approvals; EAEU certs align with global norms for expedited GCC entry via reliance on EMA/FDA equivalents.

Reduced national filings, faster unified access.

Mutual Recognition of GMP

GCC advances joint GMP inspections for mutual recognition; EAEU GMP increasingly accepted under FTAs.

Minimized duplicate audits, seamless compliance transfer.

Other Facilitation Measures

SFDA/UAE accept prior approvals from stringent regulators; shared clinical data and supply chain standards.

Cut timelines/costs by up to 30%, eased multi-country launches.

 At Soloreg, we're closely monitoring these evolving dynamics to ensure your strategies stay ahead.
Register via the EAEU with SolOReg — and leverage your approval for future GCC market entry.
 Breaking News: Soloreg is set to open a new office in Abu Dhabi soon, strengthening our on-the-ground support for MENA expansions!
Visit soloreg.com for the latest updates. Let's grow your pharma business together!
Discuss the project All Soloreg services
Made on
Tilda